Clinical Trial Update: Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of mazindol controlled release for adults with attention deficit hyperactivity disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Mazindol (mazindol)

Snippet

Sponsor: NLS Pharmaceutics | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 2 | Status: COMPLETED